Nonsteroidal antiinflammatory drug use among patients with GI bleeding.

Published

Journal Article

BACKGROUND: Previous studies have suggested that recommended gastroprotective strategies such as gastroprotective agents (GPAs) and cyclooxygenase (COX) 2 inhibitors may be underutilized among individuals at risk for nonsteroidal antiinflammatory drug (NSAID)-related gastrointestinal (GI) bleeding. OBJECTIVE: To examine the use of traditional NSAIDs, COX-2 inhibitors, and GPAs among patients recently hospitalized for GI bleeding. METHODS: This was a retrospective cohort study of a national sample of 4338 veterans hospitalized for GI bleeding between January and June 1999. Prescription drug use was examined for 6 months following hospitalization. We examined relationships of subject characteristics (age, race, gender, geographic region, diagnosis of arthritis) to prescription of a high-risk NSAID, defined as a traditional NSAID but no GPA within 60 days before or after the NSAID. RESULTS: Approximately 20% of subjects were prescribed an NSAID or COX-2 inhibitor, but only 5% were prescribed a traditional NSAID with no GPA. In a multivariable analysis, subjects <65 years of age and those with arthritis were more likely to be prescribed a traditional NSAID without a GPA. No other subject characteristics were related to receipt of a high-risk prescription. CONCLUSIONS: In a national sample of veterans with a recent hospitalization for GI bleeding, high-risk NSAID prescriptions were uncommon. Underuse of gastroprotective strategies may be more common in patients with less recent GI bleeding-related hospitalization. Strategies to remind physicians and pharmacists to screen for GI risk factors may help to sustain appropriate prescribing and reduce NSAID-related adverse events.

Full Text

Duke Authors

Cited Authors

  • Dominick, KL; Bosworth, HB; Jeffreys, AS; Grambow, SC; Oddone, EZ; Horner, RD

Published Date

  • July 1, 2004

Published In

Volume / Issue

  • 38 / 7-8

Start / End Page

  • 1159 - 1164

PubMed ID

  • 15187205

Pubmed Central ID

  • 15187205

International Standard Serial Number (ISSN)

  • 1060-0280

Digital Object Identifier (DOI)

  • 10.1345/aph.1E052

Language

  • eng

Conference Location

  • United States